Amicus Therapeutics, Inc. (FOLD) Investor Investigation over Potential Wrongdoing
An investigation on behalf of investors in NASDAQ:FOLD shares was announced over potential breaches of fiduciary duties by certain directors at Amicus Therapeutics.
View full press release